KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis

Nature Medicine

Volumn 21, Issue 6, 2015, Pages 628-637

  Shankman, Laura S ^a   Gomez, Delphine ^a   Cherepanova, Olga A ^a   Salmon, Morgan ^a   Alencar, Gabriel F ^a   Haskins, Ryan M ^a   Swiatlowska, Pamela ^a,b   Newman, Alexandra A C ^a   Greene, Elizabeth S ^a   Straub, Adam C ^c   Isakson, Brant ^a   Randolph, Gwendalyn J ^d   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF GDA SK   (Poland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHOLESTEROL; KRUPPEL LIKE FACTOR 4; APOLIPOPROTEIN E; KRUPPEL LIKE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SMOOTH MUSCLE FIBER; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRACKING; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PROMOTER REGION;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRACKING; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; PROMOTER REGIONS, GENETIC;

EID: 84930758301     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3866     Document Type: Article

References (62)

1. Saffitz, J.E. & Schwartz, C.J. Coronary atherosclerosis and thrombosis underlying acute myocardial infarction. Cardiol. Clin. 5, 21-30 (1987).
2. Libby, P. & Aikawa, M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8, 1257-1262 (2002).
3. Falk, E., Nakano, M., Benton, J.F., Finn, A.V. & Virmani, R. Update on acute coronary syndromes: the pathologists'view. Eur. Heart J. 34, 719-728 (20123).
4. Falk, E., Shah, P.K. & Fuster, V. Coronary plaque disruption. Circulation 92, 657-671 (1995).
5. Virmani, R., Kolodgie, F.D., Burke, A.P., Farb, A. & Schwartz, S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262-1275 (2000).
6. Lee, R.T. & Libby, P. The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. 17, 1859-1867 (1997).
7. Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
8. Libby, P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 2045-2051 (2012).
9. Glass, C.K. & Witztum, J.L. Atherosclerosis: the road ahead. Cell 104, 503-516 (2001).
10. Libby, P., Ridker, P.M. & Hansson, G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325 (2011).
11. Gomez, D. & Owens, G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 95, 156-164 (2012).
12. Rong, J.X., Shapiro, M., Trogan, E. & Fisher, E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. USA 100, 13531-13536 (2003).
13. Martin, K. et al. Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ. Res. 105, 214-218 (2009).
14. Caplice, N.M. et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl. Acad. Sci. USA 100, 4754-4759 (2003).
15. Iwata, H. et al. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 122, 2048-2057 (2010).
16. Wamhoff, B.R. et al. A G/C element mediates repression of the SM22α promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ. Res. 95, 981-988 (2004).
17. Feil, S. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115, 662-667 (2014).
18. Swirski, F.K. & Nahrendorf, M. Do vascular smooth muscle cells differentiate to macrophages in atherosclerotic lesions? Circ. Res. 115, 605-606 (2014).
19. Allahverdian, S., Chehroudi, A.C., McManus, B.M., Abraham, T. & Francis, G.A. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129, 1551-1559 (2014).
20. Cordes, K.R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-710 (2009).
21. Yoshida, T., Kaestner, K.H. & Owens, G.K. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102, 1548-1557 (2008).
22. Deaton, R.A., Gan, Q. & Owens, G.K. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 296, H1027-H1037 (2009).
23. Yoshida, T., Gan, Q. & Owens, G.K. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 295, C1175-C1182 (2008).
24. Thomas, J.A. et al. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am. J. Physiol. Heart Circ. Physiol. 296, H442-H452 (2009).
25. Pidkovka, N.A. et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res. 101, 792-801 (2007).
26. Alexander, M.R. & Owens, G.K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 74, 13-40 (2012).
27. Gomez, D., Shankman, L.S., Nguyen, A.T. & Owens, G.K. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat. Methods 10, 171-177 (2013).
28. Klein, D., Benchellal, M., Kleff, V., Jakob, H.G. & Ergun, S. Hox genes are involved in vascular wall-resident multipotent stem cell differentiation into smooth muscle cells. Sci. Rep. 3, 2178 (2013).
29. Klein, D. et al. Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS ONE 6, e20540 (2011).
30. Xiao, Q. et al. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 26, 2244-2251 (2006).
31. Xiao, Q., Zeng, L., Zhang, Z., Hu, Y. & Xu, Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin α1/β1/αv and PDGF receptor pathways. Am. J. Physiol. Cell Physiol. 292, C342-C352 (2007).
32. Passman, J.N. et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc. Natl. Acad. Sci. USA 105, 9349-9354 (2008).
33. McDonald, O.G., Wamhoff, B.R., Hoofnagle, M.H. & Owens, G.K. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116, 36-48 (2006).
34. Vladykovskaya, E. et al. Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids. J. Lipid Res. 52, 2209-2225 (2011).
35. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
36. Cherepanova, O.A. et al. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ. Res. 104, 609-618 (2009).
37. Salmon, M., Gomez, D., Greene, E., Shankman, L. & Owens, G.K. Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo. Circ. Res. 111, 685-696 (2012).
38. Regan, C.P., Adam, P.J., Madsen, C.S. & Owens, G.K. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J. Clin. Invest. 106, 1139-1147 (2000).
39. Feinberg, M.W. et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138-4148 (2007).
40. Liao, X. et al. Kruppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121, 2736-2749 (2011).
41. Sharma, N. et al. Myeloid Krüppel-like factor 4 deficiency augments atherogenesis in Apoe-/- mice-brief report. Arterioscler. Thromb. Vasc. Biol. 32, 2836-2838 (2012).
42. Zhou, G. et al. Endothelial Krüppel-like factor 4 protects against atherothrombosis in mice. J. Clin. Invest. 122, 4727-4731 (2012).
43. Nguyen, A.T. et al. Smooth muscle cell plasticity: fact or fiction? Circ. Res. 112, 17-22 (2013).
44. Tang, Z. et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat. Commun. 3, 875 (2012).
45. Foster, K.W. et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 1491-1500 (2005).
46. Jaubert, J., Cheng, J. & Segre, J.A. Ectopic expression of Krüppel-like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development 130, 2767-2777 (2003).
47. Katz, J.P. et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 2619-2628 (2002).
48. Katz, J.P. et al. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128, 935-945 (2005).
49. Dandré, F. & Owens, G.K. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am. J. Physiol. Heart Circ. Physiol. 286, H2042-H2051 (2004).
50. Clément, N. et al. Notch3 and IL-1β exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-κB drives crosstalk. J. Cell Sci. 120, 3352-3361 (2007).
51. Vengrenyuk, Y. et al. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 535-546 (2015).
52. Owens, G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75, 487-517 (1995).
53. Owens, G.K., Kumar, M.S. & Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801 (2004).
54. Vooijs, M., Jonkers, J. & Berns, A. A highly efficient ligand-regulated Cre recombinase mouse line shows that loxP recombination is position dependent. EMBO Rep. 2, 292-297 (2001).
55. Alexander, M.R. et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J. Clin. Invest. 122, 70-79 (2012).
56. McDonald, O.G. & Owens, G.K. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 100, 1428-1441 (2007).
57. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
58. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
59. Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008).
60. Quinlan, A.R. & Hall, I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
61. Mi, H., Muruganujan, A., Casagrande, J.T. & Thomas, P.D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551-1566 (2013).
62. Geisterfer, A.A., Peach, M.J. & Owens, G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62, 749-756 (1988).